Open Access

Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the ileum: case report of a 16-year-old Chinese female and literature review

  • Teng Li1,
  • Fang Zhang1,
  • Yarui Cao1,
  • Shoubin Ning2,
  • Yongmin Bi3,
  • Weicheng Xue4 and
  • Li Ren1Email author
Diagnostic Pathology201712:37

https://doi.org/10.1186/s13000-017-0626-3

Received: 28 November 2016

Accepted: 17 April 2017

Published: 4 May 2017

Abstract

Background

Ewing’s sarcoma (ES) and primitive neuroectodermal tumors (PNET) are closely related tumors. Although soft tissue ES/PNET are common in clinical practice, they are rare in the small intestine. Because of the absence of characteristic clinical symptoms, they are easily misdiagnosed as other benign or malignant diseases.

Case presentation

Here, we present the case of a 16-year-old female who complained of anemia and interval hematochezia. Her serum test results showed only a slight elevation of CA-125 and a low level of hemoglobin. Computer tomography and magnetic resonance imaging revealed a cystic and solid mass in the lower abdominal quadrant and pelvic region, which prompted suspicion of a malignant gastrointestinal stromal tumor of the small intestine. After resection, the tumor’s histology and immunohistochemistry (positive for CD99, vimentin and synaptophysin) results suggested ES/PNET. Fluorescent in situ hybridization tests proved the breakpoint rearrangement of the EWSR1 gene in chr 22.Ultrastructural analysis revealed neurosecretory and glycogen granules in the tumor cell cytoplasm.

Conclusions

Together, these data supported the diagnosis of a rare case of localized ES/PNET in the small intestine without adjuvant chemo- or radiotherapy. To our knowledge, this is the first report from China of a primary small bowel ES/PNET in the English-language literature. In addition, on the basis of findings from previous publications and the current case, the optimal treatment for localized gastrointestinal ES/PNET is discussed.

Keywords

Ewing’s sarcoma Primitive neuroectodermal tumor Extraosseous Small intestine FISH EWS gene

Background

Ewing’s sarcoma (ES)/primitive neuroectodermal tumor (PNET) is a small round cell tumor with simple sarcoma-specific genetic alterations resulting in TET/FET family member and ETS family member fusion proteins [1]. Pathologists no longer categorize ES and PNET as different tumors because their genetic abnormalities overlap. Instead, they are termed the Ewing’s sarcoma family of tumors [2, 3], together with the Askin tumor. ES/PNET are most commonly seen in patients younger than 20 years of age and are derived mainly from bone [4]. The tumor has been discovered in most organs, including the pancreas, liver, adrenal gland, esophagus, and uterus [511]. However, ES/PNET is extremely rare in the small bowel. Although it has been reported previously in this location [1217], none of these reports came from China. Here, we present the first reported case in China of primary ES/PNET in the ileum with EWS rearrangement.

Case presentation

Clinical history

A 16-year-old Chinese girl presented complaining of anemia and interval hematochezia. Her hemoglobin was 54 g/L on admission. Capsule endoscopy and double-balloon enteroscopy showed mucosal hyperemia, edema and mass protrusion on the ileal wall. Computed tomography (CT) scans and three-dimensional reconstruction revealed a 10.0 × 7.3 × 5.3 cm irregular mass that had developed from the ileal wall in the right lower quadrant (Fig. 1a-h). The lesion showed intense but inhomogeneous enhancement following contrast administration (Fig. 1e-h), particularly in the arterial phase. There was a small amount of effusion in the pelvic cavity. Pelvic magnetic resonance imaging (MRI) indicated a right ovarian cyst in addition to the above mass. Both CT and MRI prompted suspicion of malignant GIST of the small bowel. Her serum CA-125 was slightly increased (50.5 U/mL, standard 0–36 U/mL), but the other markers were within normal limits. The tumor and a loop of small intestine were resected through a right ventral midline incision. The patient recovered uneventfully. Postoperative bone scintigraphy proved that there was no lesion in the skeletal system (Fig. 1 d). Her chest CT scan and cerebral MRI were also unremarkable. Thus, the patient was classified as T2aN0M0 according to the 8th edition of the AJCC Cancer Staging Manual.
Fig. 1

Abdominal and pelvic CT scan, 3D reconstruction and ECT demonstrating the tumor originating in the ileum of the patient. CT scan was performed immediately after enteroscopy. Thus, the patient’s intestine was dilated. a Coronal scan arterial phase reveals that the tumor was derived from ileal wall. b 3D reconstruction with volume rendering technique illustrates the supporting vasculature. c 3D reconstruction with maximum intensity projection demonstrates major vascular support of the tumor. d Postoperative bone scintigraphy proved that there was no lesion in her skeletal system. e Plain scan revealed pelvic a 10.0 × 7.6 × 5.3 cm mass with areas of necrosis. Most of the mass was had clear boundaries with surrounding tissues, although part of it obliterated the lumen of the terminal ileum. Workup for metastasis was negative. f-h Contrast-enhanced arterial, venous, and delayed phase pelvic CT scan revealed enhancement of the solid part of the tumor in all phases, with the peak in the arterial phase

Gross features

On laparotomy, a large cystic and solid mass 10.5 cm in diameter was found arising from the ileal wall. The cut tumor surface showed large central hemorrhagic and necrotic changes and pseudocystic degeneration. The tumor tissue was mostly light gray and solid, with some softer and more friable reddish congested areas (Fig. 2).
Fig. 2

Gross features of the tumor with the resected ileum

Histological features

Cross sections revealed solid nests of small round tumor cells arising from the muscular layer and infiltrating all layers of the ileum wall. Cystic and hemorrhagic changes were seen on part of the sections, as were sharply demarcated borders that were frequently covered by intact serosa. No vascular tumor embolus or perineuronal invasion were observed. The serosal layer and the surgical margins of the specimen were free of disease. Under high-power view, tumor cells were round or elliptical, possessing scant eosinophilic cytoplasm and abortive pseudorosette formation. The tumor cell nuclei were round, with exquisite chromatin, ambiguous nucleoli, and 9/10 high-power-field pathological mitoses (Fig. 3a-c). Tumor cells showed positive immunoreactivity for Vimentin and CD99 (Fig. 3 d, j) and moderate staining for Cam5.2, Syn and PR (Fig. 3 f, g, k). Results were negative for CKpan, LCA, S-100, HMB45, Melan-A, CD31, CD34, NSE, P53, CD56, CgA, SMA, Desmin, CD117, Dog-1, ER, Bcl-2, and alpha-inhibin.
Fig. 3

Histological and immunohistochemical features of the intestinal tumor. a Low-power view with HE staining indicates sheets of tumor cells invading the myometrium and submucosa. b High-power HE view suggests that the tumor cells are small, round and form Homer-Wright structures. The boxed region is amplified in the upper right corner and is used to show pathological mitosis. c-f The tumor is positively stained for Vimentin, Syn, CD99, and the Ki-67 index is high (~40%). All immunohistochemistry images were taken under 200× magnification

FISH

Dual color break-apart probe FISH examination showed that 90% of the cells (100 counted cells per slide) exhibited 1 yellow and 1 red signal (1F1R) and that 6% of the cells exhibited 1 yellow, 1 red and 1 green (break-apart) signal (1F1G1R). However, only 4% cell had two yellow signals, which proved a break of the EWSR1 locus (2 F) (Fig. 4a-c).
Fig. 4

Dual color (red/green) break-apart probe FISH test of the tumor. a Normal karyotype cells have two yellow (red/green merged) signals (arrowheads). b Most tumor cells (90%) had one yellow (red/green merged) signal and one red signal (arrows). C. Consecutive sections were HE-stained

EM

Transmission electron microscopy revealed dense clusters of tumor cells, interspersed with a few interstitial cells (Fig. 5 a). The tumor cells were small and irregular, with scant cytoplasm and organelles, and significant nuclear atypia (Fig. 5 a). Some cells had small nucleoli (Fig. 5 a). Occasionally, gap junctions between the cells were observed (Fig. 5 b), but neuroendocrine granules in the cytoplasm were rarely seen (Fig. 5 c). Most cells had glycogen particles attached to the endoplasmic reticulum (Fig. 5 d).
Fig. 5

Ultrastructure analysis of the tumor. a At lower magnification, EM shows the general tumor ultrastructure. b Cell-cell gap junctions (blue arrow) were observed in some areas. c Neurosecretory granules (red arrow) were rarely seen in the tumor cytoplasm. d Glycogen granules (yellow arrow) existed in most tumor cells. All bars = 2000 nm

Treatments and outcome

The patient underwent an exploratory laparotomy, and tumor resection was performed along with 60 cm of ileum. The patient refused chemotherapy and/or radiotherapy as adjuvant treatments. She is currently alive (10 months after the surgery) without any signs of recurrence.

Discussion

ES/PNET belongs to a family of tumors that harbor the EWSR1-ETS fusion protein, according to recent studies [18]. It is the second most common pediatric sarcoma of bone. It most commonly arises from bone but can develop in extraskeletal sites [19]. The EWSR1 gene, together with several other genes, forms the TET family [20]. Their motif of RNA binding activity enables the EWSR1-ETS fusion protein to regulate target genes as transcription factors [21, 22]. Previous research provided evidence that mesenchymal stem cells may be candidate cells from which ES/PNET originate and that EWSR1FLI1 may be the sole initiating factor in the pathogenesis of these tumors [20, 23]. Such expression results in cell transformation, with the subsequent emergence of tumors bearing the morphological and gene expression hallmarks of Ewing’s sarcoma [24].

Gastroenterological ES/PNET is extremely rare. Here, we have summarized all previous publications of gastrointestinal ES/PNET in Table 1 [7, 12, 13, 17, 2549]. Among the 36 cases, 3 cases were derived from the esophagus, 9 from the stomach, 5 were of colorectal origin, and 19 arose from the small intestine. The patient gender ratio (female/male) was 22/14, and the ages ranged from 9 to 68 years. Thirty-one of 32 cases were positive for CD99 immunoreactivity. Fluorescent in situ hybridization or real-time PCR tests confirmed that most cases had the EWSR1-ETS fusion protein. Intriguingly, however, only 4 non-metastatic gastrointestinal ES/PNET cases were treated only by resection of the tumor. Follow-up of these cases suggested that the patients were relatively younger and had up to 20 months of disease-free survival. In the current case, the young patient also refused to take adjuvant chemo- or radiotherapy. To our delight, after the 10-month follow-up examination, the patient is currently alive and well, without any sign of recurrence.
Table 1

Review of reported cases of gastrointestinal ES/PNET

Tumor site

Age

Sex

CgA

Syn

CK

CD99

CD117

FLI1

FISH break-apart EWSR1

RT–PCR EWS–FLI1

Metastasis at diagnosis

Treatments

Follow-up

Reference

Esophagus

44

F

-

-

-

+

-

+

+

+

-

Cx

ND

Johnson AD et al.

Esophagus

56

M

-

ND

-

+

ND

ND

ND

+

Lymph nodes

Sx + ImCx

ND

Maesawa C et al.

Esophagus

21

M

ND

ND

-

-

-

ND

+

ND

-

Sx + Rx

ND

Kim SB et al.

Gastric

31

F

ND

ND

-

+

ND

+

-

+

-

Sx + Rx

3 years DFS

Khuri S et al.

Gastric

19

M

ND

ND

ND

+

+

ND

ND

ND

-

Cx

ND

Aras M et al.

Gastric

41

F

+

+

ND

+

+

ND

ND

+

Intra-peritoneal

Sx + Cx + Rx

Died 110 months after surgery

Inoue M et al.

Gastric

30

M

-

-

-

+

ND

ND

ND

ND

-

Sx

6 month DFS

Ankouz A er al

Gastric

14

M

-

-

-

+

+

ND

ND

+

Liver

Sx + Cx

24 months DFS

Czekalla R et al.

Gastric

55

M

+

+

-

+

+

-

ND

+

Lymph nodes

Sx

13 months DFS

Song JM et al.

Gastric

68

M

-

ND

-

+

+

ND

ND

+

Liver

Sx + Cx

Died 13 months after diagnosis

Rafailidis S et al.

Peri-gastric

44

F

-

-

-

+

+

ND

+

ND

-

Sx

20 months DFS

Colovic RB et al.

Gastric

63

F

ND

ND

ND

ND

ND

ND

+

+

-

Sx + Cx

ND

Maxwell AM er al

Colorectal

59

M

ND

+

-

+

-

ND

ND

+

Peritoneal dissemination

Sx

Died 7 months after diagnosis

Kuwabara K et al.

Colorectal

24

F

-

-

-

+

ND

ND

ND

+

-

Sx

20 months DFS

Tokudome N et al.

Colorectal

17

M

-

-

-

+

ND

ND

ND

+

-

Sx + Cx

1 years DFS

Drut R er al

Colorectal

34

F

ND

ND

-

+

ND

ND

ND

+

Liver

Sx + StemCx

7 years DFS

Aboumarzouk OM et al.

Colorectal

53

M

-

ND

-

+

ND

ND

ND

ND

-

Sx + Cx + Rx

Died 2 years after diagnosis

Vardy J et al.

Small bowel

21

F

ND

-

+

+

ND

ND

ND

ND

-

Sx + Cx

10 months DFS

Adair et al.

Small bowel

20

F

ND

ND

ND

+

ND

ND

+

-

-

Sx + Cx

18 months DFS

Kie et al.

Small bowel

13

M

ND

-

+

+

ND

ND

+

ND

-

Sx

1 years DFS

Sarangarajan etal

Small bowel

40

M

ND

+

-

+

ND

ND

+

ND

Intra-peritoneal

Sx + Cx

Died with recurrence 5 months after diagnosis

Horie and Kato

Small bowel

14

M

ND

-

+

+

ND

ND

+

+

-

Sx + Cx

10 month DFS

Graham et al.

Small bowel

9

F

-

-

+

ND

ND

ND

+

+

-

Sx + Cx

Died 25 months after diagnosis

Shek et al.

Small bowel

53

F

ND

ND

ND

+

ND

ND

ND

ND

-

Sx

ND

Balasubram-anina et al.

Small bowel

63

M

ND

ND

ND

+

+

ND

ND

ND

Adrenal glands + lymph nodes

Sx + Cx

ND

Kim et al.

Small bowel

44

M

ND

ND

-

+

ND

ND

ND

ND

Intra-peritoneal

Sx + Cx

Died 13 months after diagnosis

Sethi and Smith

Small bowel

32

M

ND

ND

ND

+

ND

+

+

ND

-

Sx + Cx

6 months DFS

Rodarte Shade et al.

Small bowel

15

F

ND

ND

ND

ND

ND

ND

+

+

-

Sx + Cx

ND

Vignail et al.

Small bowel

18

M

ND

ND

ND

ND

ND

ND

ND

ND

-

Sx + Cx

ND

Boehm et al.

Small bowel

18

M

+

+

+

+

+

+

+

+

Liver

Sx

Died 8 months after diagnosis

Milione M et al.

Small bowel

20

M

+

+

+

+

+

+

+

+

Liver

Sx + Cx

Died 28 months after diagnosis

Milione M et al.

Small bowel

42

M

+

+

+

+

+

+

+

+

-

Sx + Cx

Died 11 months after diagnosis

Milione M et al.

Small bowel

45

M

+

+

+

+

+

+

+

+

-

Sx + Cx

Died 13 months after diagnosis

Milione M et al.

Small bowel

15

F

+

+

+

+

+

+

+

+

-

Sx + Cx + Rx

28 months DFS

Milione M et al.

Small bowel

57

M

+

+

+

+

+

+

+

+

-

Lost

Lost

Milione M et al.

Small bowel

28

F

+

+

+

+

-

-

+

+

Liver

Sx + Cx

204 months DFS

Milione M et al.

F Female, M Male, ND Not done, Sx Surgery, Cx Chemotherapy, ImCx Immuno chemotherapy, StemCx Stem cell based chemotherapy, Rx Radiotherapy, DFS Disease free survival

To date, the 5-year survival rate of localized ES/PNET is relatively high (65%-75%). However, the outcome for metastatic patients is usually poor (<30%), despite the use of chemo- and/or radiotherapy [50]. Several studies have indicated that localized extraskeletal ES/PNET has a more favorable outcome than skeletal tumors [51, 52]. The optimal management for localized ES/PNET is still debated. The National Comprehensive Cancer Network guidelines recommend that any ES/PNET should be treated with local treatment (surgery and/or radiotherapy) plus chemotherapy [53]. Nevertheless, consistent with our findings in Table 1, others have suggested that complete surgery, if feasible, may be a better option for local disease considering the late side effects of high-dose radiotherapy especially for children [52, 54]. Because small bowel ES/PNET is extremely rare and difficult to cure, our case will contribute to the understanding of the prognosis and determination of optimal management.

In the current case, the 16-year-old female patient was initially misdiagnosed with malignant GIST because of the clinical symptoms and imaging results. To differentiate among ES/PNET, malignant GIST, clear-cell sarcoma, and synovial sarcoma, immunohistochemistry, ultrastructure analysis and FISH tests were performed. Malignant GIST usually expresses CD117, Dog-1 and CD34, which were all negative in this case. Although both synovial sarcoma and ES/PNET could have genetic rearrangements, the regions of these translocations are quite different. In ES/PNET, Chr22 EWS-FLI or EWS-FEV translocations are commonly reported [16]. However, in synovial sarcoma, SYT-SSX translocation is frequently observed [55]. Clear-cell sarcoma could be ruled out by negative immunohistochemistry for HMB45, S-100 and Melan A. A previous study also indicated the necessity of distinguishing from an intraabdominal desmoplastic small round cell tumor (IDSRCT) by histological and immunohistochemical characteristics when ES/PNET occurs in the abdominal cavity [13].

Previous demographic research has suggested that Ewing’s sarcoma is far less frequent in China than in the United States Caucasian population [56]. However, whether this finding is related to genetic background differences remains to be studied. Two recent publications noted a difference in Ewing’s sarcoma occurrence between Caucasian and Hispanic populations [57, 58]. However, they did not include a reason to explain this differences.

Conclusions

In conclusion, we have described for the first time a rare case of localized ES/PNET occurring in the small intestine in the Chinese population, as confirmed by ultrastructure and genetic analyses. This case, together with previous reports, has expanded the spectrum of tumors in the small intestine.

Abbreviations

Bcl-2: 

B cell lymphoma 2

CA-125: 

Cancer antigen- 125

CD: 

Cluster of differentiation

CgA: 

Glycoprotein hormone alpha chain

CKpan: 

Pan-cytokeratin

CT: 

Computed tomography

ER: 

Estrogen hormone receptor

ES: 

Ewing’s sarcoma

GIST: 

Gastrointestinal stromal tumor

LCA: 

Lymphocyte common antigen

MRI: 

Magnetic resonance imaging

NSE: 

Neuron-specific enolase

PNET: 

Primitive neuroectodermal tumor

SMA: 

Alpha smooth muscle actin

Declarations

Acknowledgments

The authors thank Dr. Na Jia from the Department of Pathology, Beijing Cancer Hospital, for his expert technical assistance performing FISH analyses.

Funding

This study was supported by a grant-in-aid for Scientific Research from the General Hospital of the Air Force, PLA to Ren Li and from the Junior Scientists Fund (16QNP025) to Li Teng.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

T Li performed histopathological evaluations and drafted the manuscript. L Ren conceived the study and participated in the design and preparation of the manuscript. F Zhang collected, evaluated and interpreted the clinical and surgical data. YR Cao evaluated the FISH and electron microscopic findings. SB Ning performed the gastroenterological examination and provided related data. YM Bi examined the patient with CT, MRI, and bone scintigraphy and provided related data. WC Xue discussed the pathological diagnosis and supported the FISH test. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Written informed consent was obtained from the patient for the publication of this case report and any accompanying images.

Ethical approval and consent to participate

The ethical approval and documentation for the participation and publication of this case report were waived with approval of the Institutional Review Board at the General Hospital of the Air Force, PLA.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pathology, The General Hospital of Air force, PLA
(2)
Department of Gastroenterology, The General Hospital of Air force, PLA
(3)
Department of Radio and Imaging, The General Hospital of Air force, PLA
(4)
Department of Pathology, Beijing Cancer Hospital

References

  1. Kim SK, Park YK. Ewing sarcoma: a chronicle of molecular pathogenesis. Hum Pathol. 2016;55:91–100.View ArticlePubMedGoogle Scholar
  2. Dehner LP. Primitive neuroectodermal tumor and Ewing’s sarcoma. Am J Surg Pathol. 1993;17(1):1–13.View ArticlePubMedGoogle Scholar
  3. Dehner LP. The evolution of the diagnosis and understanding of primitive and embryonic neoplasms in children: living through an epoch. Mod Pathol. 1998;11(7):669–85.PubMedGoogle Scholar
  4. Collini P, Mezzelani A, Modena P, Dagrada P, Tamborini E, Luksch R, et al. Evidence of neural differentiation in a case of post-therapy primitive neuroectodermal tumor/Ewing sarcoma of bone. Am J Surg Pathol. 2003;27(8):1161–6.View ArticlePubMedGoogle Scholar
  5. Jimenez RE, Folpe AL, Lapham RL, Ro JY, O’Shea PA, Weiss SW, et al. Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol. 2002;26(3):320–7.View ArticlePubMedGoogle Scholar
  6. Harimaya K, Oda Y, Matsuda S, Tanaka K, Chuman H, Iwamoto Y. Primitive neuroectodermal tumor and extraskeletal Ewing sarcoma arising primarily around the spinal column: report of four cases and a review of the literature. Spine (Phila Pa 1976). 2003;28(19):E408–12.View ArticleGoogle Scholar
  7. Johnson AD, Pambuccian SE, Andrade RS, Dolan MM, Aslan DL. Ewing sarcoma and primitive neuroectodermal tumor of the esophagus: report of a case and review of literature. Int J Surg Pathol. 2010;18(5):388–93.PubMedGoogle Scholar
  8. Cambruzzi E, Guerra EE, Hilgert HC, Schmitz HJ, Silva VL, Milani DM, et al. Primitive neuroectodermal tumor of the liver: a case report. Case Rep Med. 2011;2011:748194.PubMedPubMed CentralGoogle Scholar
  9. Ren YL, Tang XY, Li T. Ewing sarcoma-primitive neuroectodermal tumor of the uterus: a clinicopathologic, immunohistochemical and ultrastructural study of one case. Arch Gynecol Obstet. 2011;283(5):1139–43.View ArticlePubMedGoogle Scholar
  10. Bose P, Murugan P, Gillies E, Holter JL. Extraosseous Ewing’s sarcoma of the pancreas. Int J Clin Oncol. 2012;17(4):399–406.View ArticlePubMedGoogle Scholar
  11. Abi-Raad R, Manetti GJ, Colberg JW, Hornick JL, Shah JG, Prasad ML. Ewing sarcoma/primitive neuroectodermal tumor arising in the adrenal gland. Pathol Int. 2013;63(5):283–6.View ArticlePubMedGoogle Scholar
  12. Adair A, Harris SA, Coppen MJ, Hurley PR. Extraskeletal Ewings sarcoma of the small bowel: case report and literature review. J R Coll Surg Edinb. 2001;46(6):372–4.PubMedGoogle Scholar
  13. Shek TW, Chan GC, Khong PL, Chung LP, Cheung AN. Ewing sarcoma of the small intestine. J Pediatr Hematol Oncol. 2001;23(8):530–2.View ArticlePubMedGoogle Scholar
  14. Batziou C, Stathopoulos GP, Petraki K, Papadimitriou C, Rigatos SK, Kondopodis E, et al. Primitive neurectodermal tumors: a case of extraosseous Ewing’s sarcoma of the small intestine and review of the literature. J BUON. 2006;11(4):519–22.PubMedGoogle Scholar
  15. Prasertvit S, Stoikes N. A rare case of ewing’s sarcoma of the small intestine. Am Surg. 2013;79(2):E78–9.PubMedGoogle Scholar
  16. Milione M, Gasparini P, Sozzi G, Mazzaferro V, Ferrari A, Casali PG, et al. Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly reported EWSR1-FEV translocation. Histopathology. 2014;64(7):1014–26.View ArticlePubMedGoogle Scholar
  17. Vignali M, Zacche MM, Messori P, Natale A, Busacca M. Ewing’s sarcoma of the small intestine misdiagnosed as a voluminous pedunculated uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol. 2012;162(2):234–5.View ArticlePubMedGoogle Scholar
  18. Thompson LD. Ewing sarcoma and primitive neuroectodermal tumor. Ear Nose Throat J. 2007;86(2):79–80.PubMedGoogle Scholar
  19. Sandberg AA, Bridge JA. Updates on cytogenetics and molecular genetics of bone and soft tissue tumors: Ewing sarcoma and peripheral primitive neuroectodermal tumors. Cancer Genet Cytogenet. 2000;123(1):1–26.View ArticlePubMedGoogle Scholar
  20. Riggi N, Cironi L, Suva ML, Stamenkovic I. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET. J Pathol. 2007;213(1):4–20.View ArticlePubMedGoogle Scholar
  21. Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature. 1993;363(6430):640–4.View ArticlePubMedGoogle Scholar
  22. Ohno T, Ouchida M, Lee L, Gatalica Z, Rao VN, Reddy ES. The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene. 1994;9(10):3087–97.PubMedGoogle Scholar
  23. Riggi N, Suva ML, Suva D, Cironi L, Provero P, Tercier S, et al. EWS-FLI-1 expression triggers a Ewing’s sarcoma initiation program in primary human mesenchymal stem cells. Cancer Res. 2008;68(7):2176–85.View ArticlePubMedGoogle Scholar
  24. Castillero-Trejo Y, Eliazer S, Xiang L, Richardson JA, Ilaria Jr RL. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors. Cancer Res. 2005;65(19):8698–705.View ArticlePubMedGoogle Scholar
  25. Horie Y, Kato M. Peripheral primitive neuroectodermal tumor of the small bowel mesentery: a case showing perforation at onset. Pathol Int. 2000;50(5):398–403.View ArticlePubMedGoogle Scholar
  26. Sarangarajan R, Hill DA, Humphrey PA, Hitchcock MG, Dehner LP, Pfeifer JD. Primitive neuroectodermal tumors of the biliary and gastrointestinal tracts: clinicopathologic and molecular diagnostic study of two cases. Pediatr Dev Pathol. 2001;4(2):185–91.View ArticlePubMedGoogle Scholar
  27. Balasubramanian B, Dinakarababu E, Molyneux AJ. Primary primitive neuroectodermal tumour of the small bowel mesentery: case report. Eur J Surg Oncol. 2002;28(2):197–8.View ArticlePubMedGoogle Scholar
  28. Graham DK, Stork LC, Wei Q, Ingram JD, Karrer FM, Mierau GW, et al. Molecular genetic analysis of a small bowel primitive neuroectodermal tumor. Pediatr Dev Pathol. 2002;5(1):86–90.View ArticlePubMedGoogle Scholar
  29. Maesawa C, Iijima S, Sato N, Yoshinori N, Suzuki M, Tarusawa M, et al. Esophageal extraskeletal Ewing’s sarcoma. Hum Pathol. 2002;33(1):130–2.View ArticlePubMedGoogle Scholar
  30. Tokudome N, Tanaka K, Kai MH, Sueyoshi K, Matsukita S, Setoguchi T. Primitive neuroectodermal tumor of the transverse colonic mesentery defined by the presence of EWS-FLI1 chimeric mRNA in a Japanese woman. J Gastroenterol. 2002;37(7):543–9.View ArticlePubMedGoogle Scholar
  31. Drut R, Drut M, Muller C, Marron A. Rectal primitive neuroectodermal tumor. Pediatr Pathol Mol Med. 2003;22(5):391–8.View ArticlePubMedGoogle Scholar
  32. Czekalla R, Fuchs M, Stolzle A, Nerlich A, Poremba C, Schaefer KL, et al. Peripheral primitive neuroectodermal tumor of the stomach in a 14-year-old boy: a case report. Eur J Gastroenterol Hepatol. 2004;16(12):1391–400.View ArticlePubMedGoogle Scholar
  33. Soulard R, Claude V, Camparo P, Dufau JP, Saint-Blancard P, Gros P. Primitive neuroectodermal tumor of the stomach. Arch Pathol Lab Med. 2005;129(1):107–10.PubMedGoogle Scholar
  34. Vardy J, Joshua AM, Clarke SJ, Yarrow PM, Lin BP. Small blue cell tumors of the rectum. Case 1. Ewing’s sarcoma of the rectum. J Clin Oncol. 2005;23(4):910–2.View ArticlePubMedGoogle Scholar
  35. Kuwabara K, Ishida H, Shirakawa K, Yokoyama M, Nakada H, Hayashi Y, et al. Primitive neuroectodermal tumor arising in the colon: report of a case. Surg Today. 2006;36(2):193–7.View ArticlePubMedGoogle Scholar
  36. Kim DW, Chang HJ, Jeong JY, Lim SB, Lee JS, Hong EK, et al. Ewing’s sarcoma/primitive neuroectodermal tumor (ES/PNET) of the small bowel: a rare cause of intestinal obstruction. Int J Colorectal Dis. 2007;22(9):1137–8.View ArticlePubMedGoogle Scholar
  37. Sethi B, Smith GT. Primary primitive neuroectodermal tumour arising in the small bowel. Histopathology. 2007;50(5):665–6.View ArticlePubMedGoogle Scholar
  38. Colovic RB, Grubor NM, Micev MT, Matic SV, Atkinson HD, Latincic SM. Perigastric extraskeletal Ewing’s sarcoma: a case report. World J Gastroenterol. 2009;15(2):245–7.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Rafailidis S, Ballas K, Psarras K, Pavlidis T, Symeonidis N, Marakis G, et al. Primary Ewing sarcoma of the stomach--a newly described entity. Eur Surg Res. 2009;42(1):17–20.View ArticlePubMedGoogle Scholar
  40. Ankouz A, Elbouhadouti H, Lamrani J, Bouassria A, Louchi A, Taleb KA. [Peripheral primitive neuroectodermal tumor with gastric primary location: about a new case]. Pan Afr Med J. 2010;6:15.PubMedGoogle Scholar
  41. Inoue M, Wakai T, Korita PV, Sakata J, Kurosaki R, Ogose A, et al. Gastric Ewing sarcoma/primitive neuroectodermal tumor: A case report. Oncol Lett. 2011;2(2):207–10.PubMedPubMed CentralGoogle Scholar
  42. Rodarte-Shade M, Palomo-Hoil R, Vazquez J, Ancer A, Vilches N, Flores-Gutierrez JP, et al. Primitive Neuroectodermal Tumor (PNET) of the Small Bowel in a Young Adult with Lower Gastrointestinal Bleeding. J Gastrointest Cancer. 2012;43 Suppl 1:S243–5.View ArticlePubMedGoogle Scholar
  43. Aras M, Dede F, Dane F, Aktas B, Turoglu HT. FDG PET/CT appearance of portal vein tumor thrombus in the gastric primitive neuroectodermal tumor: uncommon primary tumor site with rare finding. Clin Nucl Med. 2013;38(1):47–9.View ArticlePubMedGoogle Scholar
  44. Insabato L, Guadagno E, Natella V, Somma A, Bihl M, Pizzolorusso A, et al. An unusual association of malignant gastrointestinal neuroectodermal tumor (clear cell sarcoma-like) and Ewing sarcoma. Pathol Res Pract. 2015;211(9):688–92.View ArticlePubMedGoogle Scholar
  45. Kim SB, Lee SH, Gu MJ. Esophageal subepithelial lesion diagnosed as malignant gastrointestinal neuroectodermal tumor. World J Gastroenterol. 2015;21(18):5739–43.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Boland JM, Folpe AL. Oncocytic variant of malignant gastrointestinal neuroectodermal tumor: a potential diagnostic pitfall. Hum Pathol. 2016;57:13–6.View ArticlePubMedGoogle Scholar
  47. Khuri S, Gilshtein H, Sayidaa S, Bishara B, Kluger Y. Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Stomach. Case Rep Oncol. 2016;9(3):666–71.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Maxwell AW, Wood S, Dupuy DE. Primary extraskeletal Ewing sarcoma of the stomach: a rare disease in an uncommon location. Clin Imaging. 2016;40(5):843–5.View ArticlePubMedGoogle Scholar
  49. Song MJ, An S, Lee SS, Kim BS, Kim J. Primitive Neuroectodermal Tumor of the Stomach: A Case Report. Int J Surg Pathol. 2016;24(6):543–7.View ArticlePubMedGoogle Scholar
  50. Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley MC, et al. Ewing Sarcoma: Current Management and Future Approaches Through Collaboration. J Clin Oncol. 2015;33(27):3036–46.View ArticlePubMedGoogle Scholar
  51. Cash T, McIlvaine E, Krailo MD, Lessnick SL, Lawlor ER, Laack N, et al. Comparison of clinical features and outcomes in patients with extraskeletal versus skeletal localized Ewing sarcoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2016;63(10):1771–9.View ArticlePubMedGoogle Scholar
  52. Galyfos G, Karantzikos GA, Kavouras N, Sianou A, Palogos K, Filis K. Extraosseous Ewing Sarcoma: Diagnosis, Prognosis and Optimal Management. Indian J Surg. 2016;78(1):49–53.View ArticlePubMedGoogle Scholar
  53. Biermann JS. Updates in the treatment of bone cancer. J Natl Compr Canc Netw. 2013;11(5 Suppl):681–3.View ArticlePubMedGoogle Scholar
  54. Qureshi SS, Laskar S, Kembhavi S, Talole S, Chinnaswamy G, Vora T, et al. Extraskeletal Ewing sarcoma in children and adolescents: impact of narrow but negative surgical margin. Pediatr Surg Int. 2013;29(12):1303–9.View ArticlePubMedGoogle Scholar
  55. Machado I, Navarro L, Pellin A, Navarro S, Agaimy A, Tardio JC, et al. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases. Ann Diagn Pathol. 2016;22:25–32.View ArticlePubMedGoogle Scholar
  56. Li FP, Tu JT, Liu FS, Shiang EL. Rarity of Ewing’s sarcoma in China. Lancet. 1980;1(8180):1255.View ArticlePubMedGoogle Scholar
  57. Lee J, Hoang BH, Ziogas A, Zell JA. Analysis of prognostic factors in Ewing sarcoma using a population-based cancer registry. Cancer. 2010;116(8):1964–73.View ArticlePubMedGoogle Scholar
  58. Jacobs AJ, Fishbein J, Levy CF, Glick RD. Chest wall Ewing sarcoma: a population-based analysis. J Surg Res. 2016;204(2):475–80.View ArticlePubMedGoogle Scholar

Copyright

© The Author(s). 2017

Advertisement